Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Expert Analyses of the following article:

Oral PBI-1402 Demonstrates Significant Activity in Chemeotherapy-Induced Anemia Phase II Clinical Trial

Source: www.pipelinereview.com
Kenneth AlgazyApril 28, 2008
A Non Epo Product for Anemia of Chemotherapy? Will this dog hunt?
Author: Kenneth Algazy, MD, Clinical Professor of Medicine , University of Pennsylvania School of Medicine - CC
This non erythropoietin (Epo) product will raise hemoglobin levels and decrease the need for transfusions.
April 25, 2008
Oral PBI-1402 from ProMetic Life Sciences Inc. Might Have the Potential to Fill the Void Left by the EPO Stimulating Agents
Author: GLG Expert Contributor
While only a Phase II study, it suggest that Oral PBI-14 may be of significant help to cancer patients who suffer from anemia caused by their chemotherapy. http://www.pipelinereview.com/content/view/19152/109/ This is especially notable given the recent saftey concerns about and decline in use of Procrit and Aranesp - the only other drugs typically used to treat chemotherapy-induced ane...

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics